<DOC>
	<DOCNO>NCT00828828</DOCNO>
	<brief_summary>The purpose study determine efficacy influenza vaccine ( antibody response ) patient sarcoidosis .</brief_summary>
	<brief_title>Antibody Response Influenza Vaccine Patients With Sarcoidosis</brief_title>
	<detailed_description>Sarcoidosis multisystem disease unclear etiology characterize presence noncaseating granuloma [ 1 ] . T helper cell response exaggerate site disease cellular immunity depress peripheral blood [ 2 ] . Cutaneous anergy , lymphopenia inversion CD4/CD8 ratio peripheral blood suggest T helper cell involvement [ 3 ] . The action humeral immune system sarcoidosis matter controversy . Standard hepatitis B virus vaccination provoke protective antibody titer patient sarcoidosis [ 3 ] . Although antibody response influenza vaccine patient sarcoidosis well describe , vaccine highly recommended patient chronic pulmonary disease asthma , COPD fibrosis [ 4 , 5 , 6 ] . In study aim evaluate humeral response influenza vaccine sarcoidosis patient assess vaccine safety .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Sarcoidosis , Pulmonary</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Sarcoidosis patient : Patients relevant clinical , radiologic histologic feature sarcoidosis ( stage ) . Signed informed consent . Organ failure ( kidney , heart , liver ) . Collagen vascular disease . Diabetes . Contraindications vaccine ( Egg allergy ) . Patients receive high dose ( &gt; 60 mg/day ) steroid therapy . Any acute disease . Conditions accompany immunosuppression ( like organ transplantation , HIV ) . Any psychological disease interfere regular followup . Inoculation influenza vaccine within past 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Influenza Vaccine</keyword>
	<keyword>Sarcoidosis</keyword>
	<keyword>Antibody</keyword>
</DOC>